Stryker price target raised to $416 from $396 at BTIG

BTIG raised the firm’s price target on Stryker (SYK) to $416 from $396 and keeps a Buy rating on the shares. The company delivered strong diversified results, though there are likely to be questions around both Inari cost synergies and the disruption to the Spine business, the analyst tells investors in a research note. The firm adds however that Stryker should come out with higher growth at higher operating margin against the backdrop of healthy end-markets.